Kim P. Kamdar's Net Worth
$2.25 Million
Who is Kim P. Kamdar?
Kim P. Kamdar has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Singular Genomics Systems, Inc., Aldeyra Therapeutics, Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, Bionano Genomics, Inc., aTYR PHARMA INC, Evofem Biosciences, Inc., Durata Therapeutics, Inc., SERA PROGNOSTICS, INC., ZOGENIX, INC., Regado Biosciences Inc, Orexigen Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, CADENCE PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..
SEC CIK
Kim P. Kamdar's CIK is 0001535065
Past Insider Trading and Trends
2016 was Kim P. Kamdar's most active year for acquiring shares with 6 total transactions. Kim P. Kamdar's most active month to acquire stocks was the month of May. 2021 was Kim P. Kamdar's most active year for disposing of shares, totalling 3 transactions. Kim P. Kamdar's most active month to dispose stocks was the month of May. 2016 saw Kim P. Kamdar paying a total of $201,000.00 for 121,333 shares, this is the most they've acquired in one year. In 2023 Kim P. Kamdar cashed out on 631,648 shares for a total of $361,986.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $10
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLAUKOS Corp (GKOS) Snapshot price: $94.4325
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $3.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
aTYR PHARMA INC (LIFE) Snapshot price: $1.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |